This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jun;14(7):569-70.

doi: 10.1016/S1470-2045(13)70157-8. Epub 2013 Apr 25.

Targeted therapy and chemoradiotherapy in oesophageal cancer

Bryan H Burmeister¹, Sandro V Porceddu

Affiliations

PMID: 23623723
DOI: 10.1016/S1470-2045(13)70157-8

Comment

Targeted therapy and chemoradiotherapy in oesophageal cancer

Bryan H Burmeister et al. Lancet Oncol. 2013 Jun.

. 2013 Jun;14(7):569-70.

doi: 10.1016/S1470-2045(13)70157-8. Epub 2013 Apr 25.

Authors

Bryan H Burmeister¹, Sandro V Porceddu

Affiliation

¹ Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia. bryan_burmeister@health.qld.gov.au

PMID: 23623723
DOI: 10.1016/S1470-2045(13)70157-8

No abstract available

PubMed Disclaimer

Comment on

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
Crosby T, Hurt CN, Falk S, Gollins S, Mukherjee S, Staffurth J, Ray R, Bashir N, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G. Crosby T, et al. Lancet Oncol. 2013 Jun;14(7):627-37. doi: 10.1016/S1470-2045(13)70136-0. Epub 2013 Apr 25. Lancet Oncol. 2013. PMID: 23623280 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information